Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: A prospective controlled assessment

American Journal of Gastroenterology

Volumn 91, Issue 3, 1996, Pages 441-447

  Sheu, Bor Shyang ^b   Lin, Ching Yih ^a   Lin, Xi Zhang ^b   Shiesh, Shu Chu ^b   Yang, Hsiao Bai ^b   Chen, Chiung Yu ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; METRONIDAZOLE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEROLOGY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AMOXICILLIN; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; PENICILLINS; PROSPECTIVE STUDIES;

EID: 0029920865     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Graham DY, Go MF. Helicobacter pylori: Current status. Gastroenterology 1993;105:279-82.
2. Dooley CP, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med 1988;108:70-9.
3. Rauws EAJ, Langenberg W, Houthoff HJ, et al. Campylobacter pylori-associated chronic active antral gastritis. Gastroenterology 1988;94: 33-40.
4. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med 1993;328:349-50.
5. Stolte M, Eidt S. Healing gastric MALT lymphoma by eradicating H. pylori? Lancet 1993;342:568.
6. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994;73:2691-4.
7. Graham DY, Lew GM, Klein PD, et al. Effects of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
8. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer disease associated with eradication of Helicobacter pylori. Lancet 1990;339:1233-5.
9. O'Connor HJ. The role of Helicobacter pylori in peptic ulcer disease. Scand J Gastroenterol 1994;201(suppl):11-5.
10. Graham DY. Evolution of concepts regarding Helicobacter pylori: From a cause of gastritis to a public health problem. Am J Gastroenterol 1994;89:469-72.
11. Graham DY, Borsch GM. The who's and when's of therapy for Helicobacter pylori. Am J Gastroenterol 1990;85:1552-5.
12. Rokkas T, Pursey C, Uzoechina E, et al. Non-ulcer dyspepsia and short-term De-Nol therapy: A placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 1988;29:1386-91.
13. Loffield RJLF, Stobberingh E, Flendrig JA, et al. Presence of Helicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characterisitcs. Digestion 1990;47:29-34.
14. Marshall BJ. Campylobacter pylori: Addressing the controversies. In: Menge H, Gregor M, Tytgat GNJ, eds. Campylobacter pylori. Berlin: Springer-Verlag, 1988:235-45.
15. Yoshida N, Granger DN, Evans DJ Jr, et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993;105:1431-40.
16. Solcia E, Villani L, Fiocca R, et al. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994;201(suppl):28-34.
17. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Modern Pathol 1993;6: 281-9.
18. Vaira D, Holton J, Falzon M. The benefit of treating dyspeptic patients with normal endoscopic appearance. Rev Esp Enferm Dig 1990; 78(suppl 1):106-7.
19. Lambert JR, Dunn K, Borromeo M, et al. Campylobacter pylori: A role in non-ulcer dyspepsia? Scand J Gastroenterol 1989;160(suppl 24):7-13.
20. McCarthy C, Patchett S, Collins RM, et al. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40:114-9.
21. Alam K, Schubert TT, Bologna SD, Ma CK. Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. Am J Gastroenterol 1992;87:424-8.
22. Price AB. The Sydney system: Histological division. J Gastroenterol Hepatol 1991;6:209-22.
23. Veenendall RA, Peña AS, Meijer JL, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32:1291-4.
24. Rokkas T, Pursey C, Uzoechina E, et al. Campylobacter pylori and non-ulcer dyspepsia Am J Gastroenterol 1987;53:1663-9.
25. Kang JY, Tay HH, Wee A, et al. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia: A double blind placebo controlled study. Gut 1990;31:476-80.
26. Minocha A, Mokshagundam S, Gallo SH, et al. Alternations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol 1994;89:1797-800.
27. Waldron B, Cullen PT, Kumar R, et al. Evidence for hypomotility in non-ulcer dyspepsia: A prospective multifactorial study. Gut 1991;32: 246-51.
28. Talley NJ, Phillips SN. Non-ulcer dyspepsia: Potential causes and pathophysiology. Ann Intern Med 1988;108:865-79.
29. Ormand JE, Talley NJ. Helicobacter pylori: Controversies and an approach to management. May Clin Proc 1990;65:414-26.
30. Marshall BJ, Valenzuela JE, McAllum RW, et al. A placebo controlled trial of bismuth subsalicylate for the treatment of Helicobacter pylori associated gastritis. Gastroenterology 1990;98(suppl):A83.
31. Loffield RJL, Potters HV, Stobberingh E, et al. Campylobacter-associated gastritis in patients with non-ulcer dyspepsia: A double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 1989; 80:1206-12.
32. Yang JC, Yang CK, Lin JT, et al. Metronidazole-resistant Helicobacter pylori in the Taiwanese with duodenal ulcer. Chin J Gastroenterol 1994;11:253.
33. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
34. Patchett S, Beattie S, Leen E, et al. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. Br Med J 1991;303:1238-40.
35. Genta RM, Hamner HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: Frequency, distribution, and response to triple therapy. Hum Pathol 1993;24:577-83.
36. Wang WM, Chen CY, Jan CM, et al. Long-term follow-up and serologic study after triple therapy of Helicobacter pylori-associated duodenal ulcer. Am J Gastroenterol 1994;89:1793-6.